Fazirsiran (TAK-999, ARO-AAT)

Fazirsiran · Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fazirsiran (TAK-999, ARO-AAT), covering 2025-04-20 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD) [Phase 2]

See pricing